Use of an opioid molecule for treating dry eye and eyes suffering from allergies
AssigneesH4 Orphan Pharma, Gaëtan Terrasse
InventorsGaëtan Terrasse, Catherine Bur
Life of this patent
Estimating the term…
Abstract
The use of an opioid molecule, the levorotatory and dextrorotatory enantiomers of (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3] dioxolo [4,5-glisoquinolin-5-yl]-3H-2-benzofuran-1-one, capable of CFTR modulation and of suppressing the degranulation of basophils and mast cells, for the treatment of dry eye and eyes suffering from allergies.
Claims5
A method of treating dry eye disease comprising administering (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3] dioxolo [4,5-g] isoquinolin-5-yl]-3H-2-benzofuran-1-one, its enantiomer, or a pharmaceutically-acceptable salts thereof, to a patient in need.
Dependencies are inferred from the claim text.